Galderma Products: Complete Guide for Aesthetic Practices

Key Takeaways

• Galderma is a pure-play dermatology leader founded in 1981, operating in approximately 90 countries with a comprehensive portfolio spanning Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology.
• All primary Galderma aesthetic products are FDA-approved, with Restylane fillers backed by over 27 years of clinical data and Dysport approved for cosmetic use since 2009.
• Wholesale pricing typically runs $3–$4 per unit for Dysport and $150–$200 per syringe for Restylane, offering favorable margins compared to some competitors when your purchasing volume supports tiered pricing.
• Galderma products for face treatments include the world's most diverse range of hyaluronic acid fillers, offering practitioners flexibility to customize treatment protocols across different facial zones.
• Portrait Care offers tiered pricing, bulk discounts, and streamlined ordering to help clinics source Galderma products profitably.

When patients walk into your clinic asking for Restylane or Dysport by name, they're referring to products from Galderma. This pure-play dermatology category leader has been dedicated to skin health for over 4 decades.

About Galderma

Galderma was founded in 1981 as a joint venture between Nestlé and L'Oréal, and has since established itself as a research-driven dermatology company. After Nestlé acquired L'Oréal's stake in 2014 to create Nestlé Skin Health, the company was sold to a consortium of private institutional investors in 2019 for $10.2 billion. In March 2024, Galderma completed one of the largest healthcare IPOs ever, listing on the Swiss Exchange (SIX: GALD).

Today, Galderma operates from its headquarters in Zug, Switzerland, under the leadership of CEO Flemming Ørnskov, M.D., MPH. The company's products are sold in over 100 countries, and its injectable aesthetics portfolio—particularly Restylane and Dysport—remains the category standard for practitioners seeking alternatives to Allergan.

Galderma at a Glance

• Parent company: Galderma S.A. (SIX: GALD)
• IPO completed: March 2024 (Swiss Exchange)
• Headquarters: Zug, Switzerland
• Primary aesthetic products: Restylane, Dysport, Sculptra, Alastin
• Market position: Pure-play dermatology category leader
• Regulatory status: FDA-approved injectables, fillers, and therapeutics
• Geographic reach: 100+ countries

Who Owns Galderma?

Which company owns Galderma? Following its March 2024 IPO, Galderma became a publicly traded company on the Swiss Exchange. Before that, ownership was held by a consortium led by EQT, alongside Abu Dhabi Investment Authority (ADIA) and PSP Investments. In August 2024, L'Oréal acquired a 10% stake in Galderma, reconnecting two companies that share historical roots while establishing a scientific partnership for future innovation.

Does Galderma Own Cetaphil?

Yes, Galderma owns Cetaphil. The sensitive skincare brand has been part of Galderma's dermatological skincare portfolio for decades and surpassed $1 billion in annual sales in 2023. Cetaphil has been recommended by dermatologists for over 70 years and is sold in approximately 100 countries worldwide.

Is CeraVe Owned by Galderma?

No, CeraVe is not owned by Galderma. CeraVe is owned by L'Oréal and is a direct competitor to Galderma's Cetaphil brand in the dermatological skincare market. While L'Oréal now holds a 10% stake in Galderma and the two companies have formed a scientific partnership, Cetaphil and CeraVe remain separate, competing brands.

Galderma Product List

Galderma's product lineup spans three primary business segments, each addressing specific treatment needs and patient demographics. Understanding these categories helps you build a service menu that meets demand while maximizing your clinic's profitability.

1. Injectable Aesthetics

The flagship category includes neuromodulators (Dysport, Azzalure, and the recently approved Relfydess) and the Restylane collection of hyaluronic acid dermal fillers. These Galderma products for face treatments address dynamic wrinkles, volume loss, and facial contouring—the treatments that drive repeat visits and patient loyalty for most med spas.

2. Biostimulators

Sculptra represents Galderma's biostimulator offering, using poly-L-lactic acid (PLLA-SCA™) to stimulate natural collagen production rather than simply filling volume. Results develop gradually over several months and can last more than two years, making it an attractive option for patients seeking long-term rejuvenation. Learn more about biostimulator treatments for your practice.

3. Dermatological Skincare

Cetaphil and Alastin offer professional skincare products designed to complement injectable treatments. For clinics looking to extend patient relationships beyond treatment appointments, skincare services can generate recurring revenue and build long-term loyalty.

4. Therapeutic Dermatology

Beyond cosmetic applications, Galderma offers prescription treatments for acne, rosacea, and atopic dermatitis. Galderma products for acne include Differin (adapalene) and Benzac (benzoyl peroxide), while Galderma products for eczema now include the recently FDA-approved Nemluvio (nemolizumab) for moderate-to-severe atopic dermatitis.

What Does Galderma Make? Top Products Overview

1. Dysport (abobotulinumtoxinA)

Dysport is Galderma's flagship neuromodulator, competing directly with BOTOX Cosmetic for wrinkle relaxation treatments. It received FDA approval for cosmetic use in 2009 and has built a reputation for a faster onset and broader diffusion than some competitors.

• Typical wholesale cost: $3–$4 per unit (varies by volume and supplier)
• Clinical use: 50–120 units per treatment session (conversion ratio approximately 2.5–3 Dysport units per 1 BOTOX unit)
• Market position: Second-largest neurotoxin brand in the U.S.

Dysport's broader spread makes it particularly effective for larger treatment areas, such as the forehead. At the same time, its faster onset (often visible within 2–3 days versus 5–7 days for BOTOX) appeals to patients seeking quicker results. For practitioners wondering about Galderma products, Botox alternatives, Dysport offers comparable results with potential cost advantages when accounting for the unit conversion ratio.

2. Restylane Collection

The Restylane portfolio represents the world's most diverse range of hyaluronic acid fillers, backed by over 27 years of clinical data. Unlike single-technology approaches, Restylane encompasses three distinct technologies—NASHA®, OBT™/XpresHAn™, and the new NASHA HD™—each engineered for different treatment applications.

Restylane-L serves as the classic formulation for moderate to severe facial wrinkles and lip augmentation. The NASHA technology delivers natural-looking correction with a proven safety profile.

Restylane Lyft offers a firmer formulation for cheek augmentation and deep fold correction. Its higher G' value provides the structural support needed for significant volume restoration.

Restylane Defyne uses XpresHAn technology to provide flexible support for deeper facial lines while maintaining natural facial movement. Patients appreciate results that allow regular expression.

Restylane Refyne provides softer correction for moderate lines and folds, ideal for patients who want enhancement without stiffness.

Restylane Kysse was developed explicitly for lip augmentation, using XpresHAn technology for flexible, natural-feeling lip enhancement and correction of perioral lines.

Restylane Volyme delivers mid-face volumization with a soft, natural feel—ideal for cheek enhancement in patients seeking subtle rejuvenation.

Restylane SHAYPE represents the newest innovation, powered by NASHA HD technology for chin augmentation with bone-mimicking properties.

• Typical wholesale cost: $150–$200 per syringe (varies by formulation and volume)
• Clinical use: 0.5–2 mL per treatment, depending on product and treatment area
• Market position: World's most diverse filler portfolio with the most extended clinical history

For clinics comparing Galderma products' filler options against competitors, the Restylane portfolio offers unmatched versatility—you can address virtually any facial zone with products specifically engineered for that application, rather than adapting a one-size-fits-all approach. Explore the differences in our guide to Restylane vs. JUVÉDERM.

3. Sculptra (poly-L-lactic acid)

Sculptra takes a fundamentally different approach to facial rejuvenation. Rather than filling volume directly, it stimulates your skin's natural collagen production through its unique PLLA-SCA formulation.

• Technology: Poly-L-lactic acid microparticles activate collagen type I production
• Results timeline: Gradual improvement over 3–6 months as collagen develops
• Duration: Results can last more than two years
• Typical patient cost: $800–$1,200 per vial (often requiring multiple vials per treatment series)

Sculptra appeals to patients seeking natural-looking rejuvenation that develops gradually, avoiding the "just had work done" appearance that concerns some first-time injectable patients. The extended duration between maintenance treatments also appeals to patients who prefer fewer clinic visits.

4. Relfydess (RelabotulinumtoxinA)

Relfydess represents Galderma's newest neuromodulator innovation—the first and only ready-to-use liquid neurotoxin. Developed using Galderma's proprietary PEARL technology, Relfydess eliminates the reconstitution step that creates variability with traditional powder-form neurotoxins.

• Key innovation: Pre-mixed liquid formulation eliminates reconstitution errors
• Onset: Fast results with sustained duration
• Status: Approved in select markets; regulatory applications ongoing globally

For high-volume practices, Relfydess offers workflow efficiencies and consistent dosing, improving both patient outcomes and practice efficiency.

5. Cetaphil

Cetaphil's dermatologist-recommended skincare line has been trusted for sensitive skin for over 75 years. The portfolio includes cleansers, moisturizers, and UV protective products formulated for compromised and sensitive skin.

• Market position: Global leader in sensitive skincare
• Sales milestone: Surpassed $1 billion in annual sales in 2023
• Professional discount: Typically 40–50% off retail pricing

For aesthetic practices, recommending Cetaphil extends patient relationships beyond treatment appointments and positions your clinic as a comprehensive skin health resource. Cetaphil products pair well with post-procedure care protocols following injectable treatments.

6. Alastin Skincare

Alastin offers medical-grade skincare specifically designed to support skin's appearance following aesthetic procedures and to restore skin health daily. With over 25 published clinical studies, Alastin products are backed by rigorous scientific evidence.

• Key products: TriHex Technology products for procedure preparation and recovery
• Clinical backing: 25+ published studies
• Professional discount: Varies by account tier

Alastin represents a premium upsell opportunity for practices focused on comprehensive patient care and maximizing results from injectable treatments.

7. Galderma Products for Acne

Galderma's therapeutic dermatology portfolio includes proven acne treatments available both by prescription and over-the-counter:

Differin (adapalene) is a topical retinoid that normalizes the accumulation of skin cells that plug pores. The 0.1% formulation is available over the counter, while the 0.3% formulation requires a prescription. Differin works inside pilosebaceous units to control the buildup that leads to acne lesions while decreasing local inflammation.

Benzac offers a range of benzoyl peroxide products for acne treatment and management, including cleansers, spot treatments, and moisturizers. The antibacterial action targets acne-causing bacteria, while the complete regimen approach helps prevent new breakouts.

Epiduo/Epiduo Forte combines adapalene and benzoyl peroxide in a single prescription formulation for patients needing both active ingredients.

8. Galderma Products for Eczema

Galderma expanded significantly into therapeutic dermatology with the 2024 FDA approval of Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis. This represents a significant advancement for patients who haven't responded adequately to topical treatments.

Nemulvio is the first approved monoclonal antibody targeting the IL-31 receptor alpha. IL-31 drives itch and inflammation in atopic dermatitis, making it a key therapeutic target. In clinical trials, nearly half of patients achieved significant itch reduction within weeks of starting treatment.

According to Galderma's regulatory announcements, Nemluvio received FDA approval in December 2024 for patients 12 years and older with moderate-to-severe atopic dermatitis, in combination with topical corticosteroids and/or calcineurin inhibitors. This approval followed Nemluvio's August 2024 approval for adults with prurigo nodularis.

Wholesale vs. Retail Pricing

Understanding the spread between what you pay and what patients pay determines whether Galderma products work for your clinic's economics.

What Clinics Pay (Wholesale)

• Dysport: $3–$4 per unit
• Restylane products: $150–$200 per syringe
• Sculptra: $250–$350 per vial
• Cetaphil/Alastin: 40–50% professional discount off retail

What Patients Pay (Typical Retail)

• Dysport: $4–$8 per unit (often 50–120 units per treatment at $200–$600)
• Restylane products: $500–$800 per syringe
• Sculptra: $800–$1,200 per vial
• Cetaphil/Alastin: Full retail pricing as listed

The math matters here. If your Dysport wholesale runs $3.50 per unit and you charge $5, your margin is $1.50 per unit. On a 60-unit treatment, that's $90 gross margin per patient. At higher volumes with better wholesale pricing, margins improve significantly. That's why your supplier relationship—and the pricing tiers you can access—directly impacts whether Galderma products make sense for your practice.

Are Galderma Products FDA-Approved?

Running an aesthetic clinic means meeting strict regulatory standards. Here's what you need to know about compliance when stocking Galderma products.

FDA Approval Status

All primary Galderma aesthetic products carry FDA approval:

Dysport received FDA approval for cosmetic use (glabellar lines) in 2009. Additional approvals cover cervical dystonia and various forms of muscle spasticity. According to the FDA's approved drugs database, Dysport maintains a robust safety profile with well-characterized adverse event patterns.

Restylane collection products hold FDA approval for dermal augmentation across their various formulations. Each product carries specific indications for treatment areas and patient populations, with Restylane-L approved since 2003 and newer formulations receiving approval as they've been developed.

Sculptra received FDA approval for the correction of shallow-to-deep nasolabial fold contour deficiencies and other facial wrinkles in immunocompetent patients. Initially approved for HIV-related facial lipoatrophy, its aesthetic indications have expanded significantly.

Nemluvio received FDA approval in August 2024 for prurigo nodularis and in December 2024 for moderate-to-severe atopic dermatitis—representing Galderma's newest therapeutic approval.

Practitioner Licensing Requirements

Licensing requirements vary by state and treatment type. Generally:

Injectables (Dysport, Restylane, Sculptra) require administration by licensed physicians, nurse practitioners, or physician assistants under physician supervision. Some states allow licensed RNs to inject under specific protocols, but medical oversight remains essential.

Skincare (Cetaphil, Alastin) has no license restrictions on recommendations or sales, making it an accessible revenue source for all staff members.

Storage and Handling Requirements

Dysport requires refrigeration at 2–8°C and must be reconstituted immediately before use. Restylane products should be stored at room temperature (up to 25°C) and protected from freezing. Products must remain in original packaging with lot numbers tracked for traceability. Expired products cannot be used and require appropriate disposal—a cost that adds up if you're not managing inventory effectively.

Pros, Cons, and Best Fit

Advantages of Galderma Products

• Diverse filler portfolio means practitioners can choose the optimal product for each treatment zone rather than adapting a limited selection. The Restylane collection offers a greater variety of formulations than any single competitor.
• Favorable pricing for neurotoxins makes Dysport attractive for margin-conscious practices. When accounting for the unit conversion ratio, Dysport often delivers comparable results at a lower total cost.
• Decades of clinical research establish clear safety and efficacy profiles. Over 27 years of Restylane data and extensive Dysport research create confidence among practitioners and patients alike.
• Comprehensive skincare integration through Cetaphil and Alastin lets you source injectables and professional skincare from a single supplier, simplifying vendor management.
• FDA-approved products provide regulatory certainty with clear labeling and established protocols, reducing compliance risk for your practice.
• Growing therapeutic portfolio with Nemluvio positions practices to serve patients with dermatological conditions beyond purely aesthetic concerns.

Disadvantages of Galderma Products

• Lower brand recognition than BOTOX means some patients specifically request the Allergan brand. Converting these patients requires education about equivalent results.
• Unit conversion complexity for Dysport can confuse patients when comparing prices across practices that use different products.
• Sculptra's gradual results require strong patient communication—those expecting immediate gratification may be disappointed by the multi-month development timeline.
• Training requirements for the diverse filler portfolio mean staff need familiarity with multiple formulations and their optimal applications.

Best Fit for Galderma Products

Galderma products work well for:

• Practices seeking neurotoxin alternatives to BOTOX at competitive pricing
• Clinics that want a comprehensive filler portfolio for customized treatment planning
• Multi-service clinics looking to pair injectables with professional skincare
• Practitioners seeking products with long-term clinical data
• Growing aesthetics practices prioritizing margin optimization

Galderma products may not be ideal for:

• Practices where patients exclusively demand BOTOX by name
• Clinics seeking the single most-recognized brand, regardless of cost
• Startups with limited training bandwidth for multiple product lines

Alternatives to Galderma Products

Understanding your options helps you build a product mix that balances brand recognition, margin requirements, and patient preferences.

Injectable Alternatives

• BOTOX Cosmetic (onabotulinumtoxinA) remains the most recognized neurotoxin brand globally. Higher per-unit wholesale cost ($10–$15) but requires fewer units per treatment. Brand recognition supports premium pricing in many markets.
• JUVÉDERM Collection (Allergan/AbbVie) competes directly with Restylane. The VYCROSS technology offers different handling characteristics that some injectors prefer. Strong brand awareness but typically higher wholesale costs.
• Xeomin (incobotulinumtoxinA) offers a "naked" neurotoxin without accessory proteins, appealing to patients concerned about antibody formation. Pricing similar to Dysport.
• Radiesse (Merz) uses calcium hydroxyapatite for longer duration (12+ months) than HA fillers. Provides biostimulation similar to Sculptra but with immediate volume.

Why Practitioners Choose Alternatives

Brand recognition drives many decisions—BOTOX and JUVÉDERM command premium positioning that simplifies patient acquisition. Some patients respond better to specific formulations, making diversification clinically valuable. And exclusive agreements with manufacturers can provide preferential pricing for committed practices.

How to Choose the Right Products

Step 1: Define Your Clinical Niche

Start by identifying your target patient demographic and treatment focus. Are you a full-service aesthetic clinic or a specialist focused on specific treatments? Do you serve luxury clientele or price-sensitive markets? What's your practitioner expertise—dermatology, plastic surgery, or nursing background? Your answers shape which products make sense for your practice.

Step 2: Evaluate Your Practice Economics

Calculate realistic margins for each product, including wholesale cost vs. retail pricing in your specific market, patient volume needed to access favorable pricing tiers, storage and handling requirements, and staff training investments.

If Dysport wholesale runs $3.50 per unit and you charge $5, your margin is $1.50 per unit. On a 60-unit treatment, that's $90 versus approximately $60–$90 with higher-priced alternatives at similar percentage markups. Understanding your economics prevents costly inventory decisions.

Step 3: Assess Market Demand in Your Geography

Research competitor pricing and patient preferences in your area. Markets with established BOTOX dominance may require education to convert patients to Dysport. Urban areas with price-conscious demographics may welcome Galderma's competitive positioning. Check local competitor websites to understand market positioning before committing to inventory.

Step 4: Consider Portfolio Breadth vs. Simplicity

Choose Galderma products if you want the broadest filler selection for customized treatment protocols, your market responds to competitive neurotoxin pricing, you value long-term clinical data and proven safety profiles, or you're building comprehensive services including skincare.

Choose alternatives if patients in your market specifically demand BOTOX or JUVÉDERM by name, you prefer working in a single-manufacturer ecosystem like Allergan/AbbVie, or simplified training on fewer products better serves your team.

Step 5: Test Before Committing

Order sample quantities of products you're considering and train staff on application and patient education. Track patient satisfaction, retention, and repeat booking rates. Monitor wholesale pricing stability over 3–6 months before making significant inventory commitments.

Step 6: Build Your Product Mix

Most successful practices use a hybrid approach: one or two neurotoxins and one primary filler brand as core products, with alternatives available for patients who prefer specific brands. Adding professional skincare extends patient relationships and increases lifetime value. Learn how to conduct expert consultations that help patients choose the right treatments.

Buy Galderma Products with Portrait Care

Your purchasing strategy determines whether premium products generate premium margins or squeeze your profitability. Assess your practice's volume needs and growth trajectory—this determines your pricing tier and negotiating leverage.

As you grow, revisit your supplier relationships quarterly. Review purchasing patterns, evaluate product performance against patient demand, and renegotiate terms as you move into higher-volume brackets. The difference between good and excellent supplier relationships often shows up directly on your bottom line.

If you're ready to stock Galderma's market-leading portfolio, Portrait Care provides the infrastructure, pricing advantages, and operational support needed to do it profitably.

Portrait Care offers:

• Tiered pricing based on monthly purchase volume
• Bulk discounts for clinics ordering large quantities
• Standing order programs for predictable products like monthly Dysport shipments
• Online ordering portal for convenience and real-time inventory tracking
• Expert guidance on building a product mix that serves your patients and your margins

Whether you're launching a new aesthetics clinic or expanding an established practice, Portrait Care can help you source Galderma products at competitive wholesale pricing while providing the operational support you need to succeed.

Speak to Portrait Care today.

‍